Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium a randomized double-blind placebo-controlled trial 英文参考文献.doc,Faghihietal.DARUJournalofPharmaceuticalSciences2012,20:
INDUCED WEIGHT-GAINACTIVATED RECEPTOR-GAMMAHIGH-FAT DIETRATAs a partial histamine H1 receptor agonist and H3 antagonist, betahistine has been reported to partially prevent olanzapine-induced dyslipidemia and obesity through a combination therapy, although the underlying epigenetic mechanisms are still not ...